The Power and Potential of Biomarkers

Oncology continues to be a rapidly changing field with scientific discoveries transforming patient treatment and care. As it stands today, advancements in biomarkers are playing a vital role in furthering drug development and personalized medical approaches. In this episode of CrownCast, host Michelle Dawn Mooney interviews Julie Mayer, Vice President of Crown Bioscience's Global Biomarker Platform, regarding the critical role of biomarkers in oncology and drug development. Julie discusses the importance of implementing biomarker strategies early in the development pipeline, covering aspects such as target identification, patient selection, and companion diagnostics.